Development and Scale-Up of a Continuous, High-Pressure, Asymmetric Hydrogenation Reaction, Workup, and Isolation

被引:111
作者
Johnson, Martin D. [1 ]
May, Scott A. [1 ]
Calvin, Joel R. [1 ]
Remacle, Jacob [1 ]
Stout, James R. [1 ,3 ]
Diseroad, William D. [1 ]
Zaborenko, Nikolay [1 ]
Haeberle, Brian D. [1 ]
Sun, Wei-Ming [1 ]
Miller, Michael T. [2 ]
Brennan, John [1 ]
机构
[1] Eli Lilly & Co, Chem Prod Res & Dev, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Analyt Sci Res & Dev, Indianapolis, IN 46285 USA
[3] D&M Continuous Solut LLC, Greenwood, IN 46143 USA
关键词
CONTINUOUS MSMPR CRYSTALLIZER; ENANTIOSELECTIVE HYDROGENATION; ALPHA; BETA-UNSATURATED KETONES; KDP CRYSTALS; KINETICS; INGREDIENTS; FLOW;
D O I
10.1021/op200362h
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A fully continuous process including an asymmetric hydrogenation reaction operating at 70 bar hydrogen, aqueous extraction, and crystallization was designed, developed, and demonstrated at pilot scale. This paper highlights safety, quality, and throughput advantages of the continuous reaction and separations unit operations. Production of 144 kg of product was accomplished in laboratory fume hoods and a laboratory hydrogenation bunker over two continuous campaigns. Maximum continuous flow vessel size in the lab hoods was 22 L glassware, and maximum plug flow tube reactor (PFR) size in the bunker was 73 L. The main safety advantages of running the hydrogenation reaction continuous rather than batch were that the flow reactor was smaller for the same throughput and, more importantly, the tubular hydrogenation reactor ran 95% liquid filled at steady state. Therefore, the amount of hydrogen in the reactor at any one time was less than that of batch. A two-stage mixed suspension mixed product removal (MSMPR) cascade was used for continuous crystallization. Impurity rejection by continuous crystallization was superior to that by batch because scalable residence time and steady-state supersaturation enabled robust and repeatable control of enantiomer rejection in a kinetic regime, although this is a nonstandard approach, debatable as an impurity control strategy. The fully continuous wet-end process running in a laboratory infrastructure achieved the same weekly throughput that would be expected from traditional batch processing in a plant module with 400 L vessels.
引用
收藏
页码:1017 / 1038
页数:22
相关论文
共 42 条
[1]   Crystallization of Cyclosporine in a Multistage Continuous MSMPR Crystallizer [J].
Alvarez, Alejandro J. ;
Singh, Aniruddh ;
Myerson, Allan S. .
CRYSTAL GROWTH & DESIGN, 2011, 11 (10) :4392-4400
[2]   Continuous Plug Flow Crystallization of Pharmaceutical Compounds [J].
Alvarez, Alejandro J. ;
Myerson, Allan S. .
CRYSTAL GROWTH & DESIGN, 2010, 10 (05) :2219-2228
[3]   Attrition behavior by micro-hardness parameters in suspension-crystallization processes [J].
Asakuma, Yusuke ;
Tetahima, T. ;
Maeda, K. ;
Hideo, M. ;
Fukeu, D. .
POWDER TECHNOLOGY, 2007, 171 (02) :75-80
[4]  
Braden T. M., 2009, Reactors and methods for processing reactants therein, Patent No. [WO/2009/023515, 2009023515]
[5]   THE MOTION OF LONG BUBBLES IN TUBES [J].
BRETHERTON, FP .
JOURNAL OF FLUID MECHANICS, 1961, 10 (02) :166-188
[6]   Rhodium-Catalyzed and Zinc(II)-Triflate-Promoted Asymmetric Hydrogenation of Tetrasubstituted α,β-Unsaturated Ketones [J].
Calvin, Joel R. ;
Frederick, Michael O. ;
Laird, Dana L. T. ;
Remacle, Jacob R. ;
May, Scott A. .
ORGANIC LETTERS, 2012, 14 (04) :1038-1041
[7]   A laboratory continuous crystallization system for aluminium hydroxide precipitation studies [J].
Chan, VA ;
Ang, HM .
JOURNAL OF CRYSTAL GROWTH, 1996, 166 (1-4) :1009-1014
[8]   Pharmaceutical Crystallization [J].
Chen, Jie ;
Sarma, Bipul ;
Evans, James M. B. ;
Myerson, Allan S. .
CRYSTAL GROWTH & DESIGN, 2011, 11 (04) :887-895
[9]   Catalytic homogeneous asymmetric hydrogenations of largely unfunctionalized alkenes [J].
Cui, XH ;
Burgess, K .
CHEMICAL REVIEWS, 2005, 105 (09) :3272-3296
[10]   Asymmetric catalytic hydrogenations at micro-litre scale in a helicoidal single channel falling film micro-reactor [J].
de Bellefon, C ;
Lamouille, T ;
Pestre, N ;
Bornette, F ;
Pennemann, H ;
Neumann, F ;
Hessel, V .
CATALYSIS TODAY, 2005, 110 (1-2) :179-187